380 related articles for article (PubMed ID: 18160579)
1. Pericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.
Kayrak M; Acar K; Yazici M; Kaya C; Ayhan SS; Gok H
Clin Appl Thromb Hemost; 2009; 15(4):465-6. PubMed ID: 18160579
[TBL] [Abstract][Full Text] [Related]
2. Aspirin in essential thrombocythemia: status quo and quo vadis.
Griesshammer M; Bangerter M; van Vliet HH; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):371-7. PubMed ID: 9263354
[TBL] [Abstract][Full Text] [Related]
3. Thrombocytosis and thrombocythemia.
Schafer AI
Blood Rev; 2001 Dec; 15(4):159-66. PubMed ID: 11792116
[TBL] [Abstract][Full Text] [Related]
4. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
5. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
6. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
Walker CW; Dawley CA; Fletcher SF
Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
[No Abstract] [Full Text] [Related]
7. Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease.
Watson PD; Joy PS; Nkonde C; Hessen SE; Karalis DG
Am J Cardiol; 2009 Oct; 104(8):1052-4. PubMed ID: 19801023
[TBL] [Abstract][Full Text] [Related]
8. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin in polycythemia vera.
Dutrillaux F; Maynadié M; Carli PM
N Engl J Med; 2004 Apr; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088322
[No Abstract] [Full Text] [Related]
10. Antiplatelet agents and arterial thrombosis.
Billett HH
Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N
Am J Hematol; 2009 Apr; 84(4):215-20. PubMed ID: 19208420
[TBL] [Abstract][Full Text] [Related]
12. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation].
Sánchez-Torrijos J; Gudín-Uriel M; Ridocci-Soriano F
Rev Esp Cardiol; 2006 Dec; 59(12):1345-6. PubMed ID: 17194433
[No Abstract] [Full Text] [Related]
13. Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting.
Serebruany V; Pokov I; Kuliczkowski W; Vahabi J; Atar D
Thromb Haemost; 2008 Aug; 100(2):314-8. PubMed ID: 18690353
[TBL] [Abstract][Full Text] [Related]
14. [Coronary heart disease patient does not tolerate acetylsalicylic acid. Can clopidogrel be prescribed?].
Rupprecht HJ
MMW Fortschr Med; 2007 Apr; 149(14):19. PubMed ID: 17668757
[No Abstract] [Full Text] [Related]
15. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén H; Agren A; Nekludov M
Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
[No Abstract] [Full Text] [Related]
16. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR;
N Engl J Med; 2005 Jul; 353(1):33-45. PubMed ID: 16000354
[TBL] [Abstract][Full Text] [Related]
17. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
Landolfi R; Di Gennaro L; Novarese L; Patrono C
Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
[TBL] [Abstract][Full Text] [Related]
19. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
20. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
Landolfi R; Cipriani MC; Novarese L
Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
